Skip to main content

Advertisement

Log in

Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak general hospital

  • Short Communication
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

We performed a cross-sectional study of the demography, clinical and laboratory features of patients with polymyositis and dermatomyositis followed up in our centre from 2006 to 2009. There were 12 cases, with the majority of them (58.3%) being woman. They have a mean age of 57.8 years and mean disease duration of 11.83 (SD 9.92) months. Our patients comprised of multi-ethnic groups with predominantly Chinese (83.3%), Sarawak natives (8.3%) and Malays (8.3%). They have a mean lag time to diagnosis of 3.67 (SD 4.27) months. Nine (75%) patients had dermatomyositis and 3(25%) had polymyositis. The common clinical manifestations found in our patients were proximal myopathy (100%), neck weakness (33.3%), dysphagia (33.3%) and interstitial lung disease (33.3%). For the nine patients with dermatomyositis, the most common dermatological manifestations were shawl sign (88.9%) and V sign (88.9%). Muscle enzymes were raised in 91.7% of patients. Electromyographies were carried out in four patients, and only one of our patients had muscle biopsy. Only 41.7% of our patients have positive ANA. The majority received prednisolone (100%) and hydroxychloroquine (58.3%). Malignancy occurred in five (three nasopharyngeal carcinomas, one sigmoid colon cancer and one lung cancer) out of the nine dermatomyositis patients but none in the polymyositis group. The mortality rate in our group was 4(33.3%) over the 4-year period. This study demonstrated the rarity of PM/DM in our centre with considerable lag time to diagnosis in our patients. Despite lack of muscle biopsy in our centre, our centre achieved appropriate diagnosis and management of PM/DM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Mastaglia FL, Phillips BA (2002) Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin North Am 28(4):723–741

    PubMed  Google Scholar 

  2. Hengstman GJ, van Venrooij WJ, Vencovsky J, Moutsopoulos HM, van Engelen BG (2000) The relative prevalence of dermatomyositis and polymyositis in Europe exhibits a latitudinal gradient. Ann Rheum Dis 59(2):141–142

    PubMed  CAS  Google Scholar 

  3. Koh ET, Seow A, Ong B, Ratnagopal P, Tjia H, Chng HH (1993) Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients. Ann Rheum Dis 52(12):857–861

    PubMed  CAS  Google Scholar 

  4. Oddis CV, Conte CG, Steen VD, Medsger TA Jr (1990) Incidence of polymyositis-dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963–1982. J Rheumatol 17(10):1329–1334

    PubMed  CAS  Google Scholar 

  5. Tong M (1995) A review of dermatomyositis cases at hospital besar Kuala Lumpur 1989–1993. Med J Malays 50(1):32–36

    CAS  Google Scholar 

  6. Health Facts Sarawak (2006) Sarawak State Health Department (Information and Documentation Unit)

  7. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis. N Engl J Med 292(7):344–347

    PubMed  CAS  Google Scholar 

  8. Uthman I, Vázquez-Abad D, Senécal JL (1996) Distinctive features of idiopathic inflammatory myopathies in French Canadians. Semin Arthr Rheum 26(1):447–458

    CAS  Google Scholar 

  9. Porkodi R, Shanmuganandan K, Parthiban M, Madhavan R, Rajendran P (2002) Clinical spectrum of inflammatory myositis in South India: a ten year study. J Assoc Phys India 50:1255–1258

    CAS  Google Scholar 

  10. Airio A, Pukkala E, Isomäki H (1995) Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol 22(7):1300–1303

    PubMed  CAS  Google Scholar 

  11. Yazici Y, Kagen LJ (2000) The association of malignancy with myositis. Curr Opin Rheumatol 12(6):498–500

    PubMed  CAS  Google Scholar 

  12. Stockton D, Doherty VR, Brewster DH (2001) Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 85(1):41–45

    PubMed  CAS  Google Scholar 

  13. Zhang W, Jiang SP, Huang L (2009) Dermatomyositis and malignancy: a retrospective study of 115 cases. Eur Rev Med Pharmacol Sci 13(2):77–80

    PubMed  Google Scholar 

  14. Peng JC, Sheen TS, Hsu MM (1995) Nasopharyngeal carcinoma with dermatomyositis. Analysis of 12 cases. Arch Otolaryngol Head Neck Surg 121(11):1298–1301

    PubMed  CAS  Google Scholar 

  15. Ee HL, Ng PP, Tan SH (2004) Exacerbation of amyopathic dermatomyositis in orientals: a high alert for nasopharyngeal carcinoma. Australas J Dermatol 45(1):77–78

    PubMed  Google Scholar 

  16. Airio A, Kautiainen H, Hakala M (2006) Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol 25(2):234–239 Epub 2006 Feb 14

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We would like to acknowledge the support of the Ministry of Health, Malaysia, for technical support of the study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. L. Teh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Teh, C.L., Wong, J.S. & Soo, H.H. Polymyositis and dermatomyositis in Sarawak: a profile of patients treated in the Sarawak general hospital. Rheumatol Int 32, 265–268 (2012). https://doi.org/10.1007/s00296-010-1745-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-010-1745-2

Keywords

Navigation